financial_disclosure

Bitmine's Crypto Treasury Hits $15.6B, Holds 4.9% of ETH Supply

Image
Bitmine's Crypto Treasury Hits $15.6B, Holds 4.9% of ETH Supply

Norwalk, Conn. – September 08, 2026 -- Bitmine Immersion Technologies (NYSE: BMNR) reported total crypto, cash and moonshot holdings of $15.6 billion as of August 30, 2026, with Ethereum holdings reaching 5,901,112 ETH.

Bitmine controls 4.9% of the entire ETH supply, nearing its 5% acquisition target

The company's ETH position, valued at $2,511 per token, represents 4.9% of the 120.7 million total ETH supply outstanding. Chairman Thomas "Tom" Lee said Bitmine is now 98% of the way toward what the company calls the "5% Alchemy" goal, achieved in just 15 months since launching its Ethereum treasury strategy on June 30, 2025. The firm added 53,501 ETH in the past week alone, marking 65 consecutive weeks of purchases.

Superluminal Medicines Closes $60M Series B for Obesity Drug

Image
Superluminal Medicines Closes $60M Series B for Obesity Drug

Boston – September 08, 2026 -- Superluminal Medicines has closed an oversubscribed $60 million Series B financing led by BVF Partners, L.P., to fund a Phase 1 clinical trial for rare genetic forms of obesity expected to begin by the end of 2026.

New investors Deep Track Capital and Perceptive Advisors join the round

The financing includes participation from new investors Deep Track Capital and Perceptive Advisors, alongside existing backers RA Capital Management, Insight Partners, NVIDIA, Catalio Capital Management, Eli Lilly and Company, Cooley, and Gaingels.

BRP Revenue Jumps 18.5% as Tariffs Drive Net Loss, Raises FY27 Guidance

Image
BRP Revenue Jumps 18.5% as Tariffs Drive Net Loss, Raises FY27 Guidance

Valcourt, QC – September 08, 2026 -- BRP Inc. (TSX: DOO; NASDAQ: DOO) reported second-quarter revenue of $2,236.8 million, up 18.5% from $1,888.2 million a year earlier, even as the company swung to a net loss of $136.8 million after tariff costs and a supplier restructuring charge hit margins.

BRP raises full-year EPS guidance to $4.00-$4.50 despite margin pressure

The company increased its Fiscal 2027 outlook, now projecting Normalized diluted earnings per share of $4.00 to $4.50, citing strong ORV performance, additional market share gains and reduced net tariff costs. North American Powersports retail sales rose 1% year-over-year, driven by positive SSV industry trends and ORV share gains, partially offset by weaker Seasonal Products sales.

LITEON Takes 25% Stake in Poland's DCX in $176M Liquid Cooling Deal

Taipei – September 08, 2026 -- LITEON Technology (2301.TW) has agreed to acquire approximately 25% equity ownership in Warsaw-based DCX Liquid Cooling Systems in a transaction valued at approximately US$176 million.

LITEON secures quarter stake in Polish cooling specialist

The deal gives the Taiwanese electronics group a strategic foothold in DCX POLSKA Sp. z o.o., a company founded in 2019 that builds coolant distribution units, facility coolant distribution units, cold plates and immersion cooling systems for AI and high-performance computing data centers.

Gan & Lee, Menarini Ink EUR726M Deal for GLP-1 Obesity Drug

Image
Gan & Lee, Menarini Ink EUR726M Deal for GLP-1 Obesity Drug

Beijing – September 08, 2026 -- Gan & Lee Pharmaceuticals (603087.SH) has signed an exclusive license agreement with Italy's Menarini Group worth up to EUR 726 million, excluding royalties, to register and commercialize its GLP-1 receptor agonist bofanglutide for obesity and overweight treatment across 39 countries.

Deal structure delivers EUR 62 million upfront with EUR 664 million in milestones

Gan & Lee will receive an upfront payment of EUR 62 million, milestone payments totaling up to EUR 664 million, and double-digit royalties on net sales in the licensed territory. Menarini takes responsibility for regulatory submissions and commercialization across the 27 EU Member States plus the United Kingdom, Switzerland, Norway, Iceland, Liechtenstein and Balkan countries.

Zinzino Group Revenue Rises 15% to SEK 282.2M in August 2026

Gothenburg – – September 07, 2026 -- Zinzino AB reported group revenue of SEK 282.2 million for August 2026, up 15% from SEK 245.9 million a year earlier, as growth in its direct-sales markets offset a sharp decline at subsidiary Faun Pharma.

Sales markets revenue climbs 16% to SEK 280.9 million in August

Zinzino's core direct-sales business generated SEK 280.9 million in August 2026, up from SEK 242.5 million in the same month last year, a 16% increase that drove the bulk of the group's top-line expansion.

Faun Pharma external sales drop to SEK 1.3 million from SEK 3.4 million

Faun Pharma's external sales fell to SEK 1.3 million in August 2026, down from SEK 3.4 million a year earlier, a decline that partially offset the stronger performance of Zinzino's sales markets and reduced the group's overall growth rate to 15% from the 16% posted by the sales markets alone.

Sivers Semiconductors Commits $30M to Scale InP Laser Output for AI Data Centers

Kista, Sweden – September 07, 2026 -- Sivers Semiconductors AB (STO: SIVE) will invest USD 30 million to expand its Indium Phosphide (InP) manufacturing facility in Glasgow, Scotland, targeting annual production of more than 100 million continuous-wave distributed feedback (CW DFB) lasers to meet surging demand from AI datacenter and optical networking customers.

Expansion timeline runs through fourth-quarter 2027

The build-out will begin in the second half of 2026 and become operational in Q4 2027, adding new process capabilities, greater automation and manufacturing flexibility to the existing Glasgow site.

Insilico Medicine Joins HKEX Tech 100 Index Amid Record AI Drug Pipeline

Cambridge – September 07, 2026 -- Insilico Medicine (HKEX: 3696) will join the HKEX Tech 100 Index effective September 14, 2026, following methodology changes announced August 18, 2026, that widen the benchmark's exposure to the AI value chain. Index changes take effect after market close on September 11, 2026 (Friday).

HKEX Tech 100 Index tracks 100 leading Hong Kong tech names across six themes

The index measures 100 of the largest Hong Kong-listed companies with high exposure to technology themes eligible for Southbound Stock Connect. It spans artificial intelligence, biotech and pharmaceutical, electric vehicles and smart driving, information technology, internet, and robotics.

Lindian Signs Carester Deal for Kazakhstan Rare Earth Oxide Plant

Image
Lindian Signs Carester Deal for Kazakhstan Rare Earth Oxide Plant

Perth – September 07, 2026 -- Lindian Resources Limited (ASX: LIN) has signed a Technology and Engineering Services Agreement and a long-term binding Offtake Agreement with Carester SAS to develop an 8,000 tonne-per-annum rare earth oxide separation facility in Stepnogorsk, Kazakhstan.

Carester and Tetra Tech Coffey to complete DFS by Q4 2026

Carester, a global rare earth processing specialist, will work with Tetra Tech Coffey to advance a Definitive Feasibility Study for the solvent extraction and oxide separation plant, targeted for completion by the fourth quarter of 2026.

Scienjoy to Buy 29.9% Stake in Leader Education for $13.1 Million

Beijing – September 07, 2026 -- Scienjoy Holding Corporation (NASDAQ: SJ) has agreed to acquire a 29.9% stake in Hong Kong-listed Leader Education Limited (HKSE: 1449.HK) for HK$102.69 million, or approximately US$13.1 million, marking the live-streaming platform operator's entry into China's private higher education sector.

Scienjoy Innovation Labs to purchase 239.2 million Leader Education shares from controlling shareholder

Under the sale and purchase agreement, Scienjoy's wholly-owned subsidiary Scienjoy Innovation Labs Inc. will buy 239,234,000 ordinary shares from Shuren Education Limited, Leader Education's controlling shareholder. The shares represent 29.9% of Leader Education's issued and outstanding share capital.